Case report: Ruxolitinib as first-line therapy for secondary hemophagocytic lymphohistiocytosis in patients with AIDS

Xiang Liu(Griffith University), Biao Zhu(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Yirui Xie(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Ying Huang(Northwestern Polytechnical University), Xiaotang Zhou(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Xueling Zhu(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Dairong Xiang(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Zhikai Wan(National Centre for Infectious Diseases)
Frontiers in Immunology
October 3, 2022
Cited by 9


Related Papers